BlackRock Virginia Municipal Bond Trust (BHV) Stock Price

10.68 ▲ +0.09 (+0.85%)
Open: 10.68 Vol: 0 Day's range: 10.68 - 10.68 Jan 16, 11:30 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BHV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 10.60▲ 10.60▲ 10.60▲ 10.59▲ 10.59▲
MA10 10.55▲ 10.58▲ 10.58▲ 10.57▲ 10.84▼
MA20 10.73▼ 10.82▼ 10.83▼ 10.56▲ 10.86▼
MA50 11.00▼ 10.98▼ 10.97▼ 10.87▼ 10.62▲
MA100 10.79▼ 10.74▼ 10.73▼ 10.81▼ 10.86▼
MA200 10.86▼ 10.89▼ 10.88▼ 10.58▲ 11.28▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.006▲ -0.015▼ -0.020▼ 0.032▲ -0.063▼
RSI 44.792▼ 44.330▼ 44.395▼ 51.055▲ 48.068▼
STOCH 57.540     34.930     34.930     74.952     21.034    
WILL %R -60.870     -60.870     -62.185     0.000▲ -64.901    
CCI 22.869     2.084     -4.948     169.113▲ -83.614    
Latest Filters Detected On BHV
RSI $BHV RSI(14) Crossed Above 50 Set Alert
MA $BHV Price Crossed Above MA(26) Set Alert
▲ BREAK $BHV Price Breaks 10 Days High Set Alert
CDL $BHV Doji Candlestick Pattern Detected Set Alert
BlackRock Virginia Municipal Bond Trust News
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Monday, January 12, 2026 08:15 AM
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad ...
Biohaven defended despite depression trial setback
Friday, December 26, 2025 04:32 AM
Biohaven (BHVN) shares fell ~15% in the premarket on Friday, even as Wall Street analysts defended the biotech in reaction to its Christmas Eve announcement regarding a failure in a Phase 2 trial for ...
Biohaven Misses The Mark In Depression Trial, Stock Falls
Friday, December 26, 2025 12:20 AM
On Wednesday, Biohaven Ltd. (NYSE: BHVN) reported results from a Phase 2 proof-of-concept study evaluating BHV-7000 for major depressive disorder (MDD). The study did not meet its primary endpoint, a ...
BHV historical stock data
date open high low close volume
16/01/26 10.68 10.68 10.68 10.68 2,563
15/01/26 10.62 10.642 10.59 10.59 13,017
14/01/26 10.57 10.58 10.56 10.56 6,100
13/01/26 10.58 10.60 10.57 10.58 1,600
12/01/26 10.59 10.65 10.52 10.56 8,300
09/01/26 10.58 10.58 10.54 10.55 2,500
08/01/26 10.51 10.51 10.51 10.51 200
07/01/26 10.54 10.59 10.52 10.59 1,600
06/01/26 10.46 10.56 10.46 10.54 2,100
05/01/26 10.56 10.56 10.45 10.52 4,100
Quote Details
52wk Low:10.01
52wk High:11.66
Vol:0
Avg Vol(3m):105.5K
1Y Chng:-2.38%
1M Chng:-1.93%
Add to Watch List
More Information
Index N/A
Market Cap. 16.78M